<p>Dr. Rybak discusses the pharmacology, safety, and emerging clinical evidence of Baricitinib in COVID19 with authors Drs. Sarah Jorgensen and Chris Tse. Full manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2438">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2438</a></p>

Dr. Rybak discusses the pharmacology, safety, and emerging clinical evidence of Baricitinib in COVID19 with authors Drs. Sarah Jorgensen and Chris Tse. Full manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2438

<p>Dr. Rybak discusses the pharmacology, safety, and emerging clinical evidence of Baricitinib in COVID19 with authors Drs. Sarah Jorgensen and Chris Tse. Full manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2438" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2438</a></p>

Baricitinib - Episode 35

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share Baricitinib - Episode 35

Sign up to save your podcasts

Baricitinib - Episode 35

Baricitinib - Episode 35

More shows like ACCP JOURNALS

EMCrit FOAM Feed

Gastropod

The Daily

Today, Explained